Empresa Jaguar Health Inc Nasdaq
Acciones
US47010C3007
Biotecnología e investigación médica
Resumen de negocios
Ventas por actividad
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Human Health
98,2
%
| 12 | 98,2 % | 10 | 98,2 % | -18,34 % |
Animal Health
1,8
%
| 0 | 1,8 % | 0 | 1,8 % | -19,53 % |
Ventas por región
USD en millones | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 12 | 100,0 % | 10 | 100,0 % | -18,36 % |
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06/06/13 |
Carol Lizak
DFI | Director of Finance/CFO | 60 | 01/05/19 |
Chief Tech/Sci/R&D Officer | 60 | 01/05/17 | |
Jonathan Wolin
CMP | Compliance Officer | 62 | 01/11/18 |
Chief Tech/Sci/R&D Officer | 62 | 01/05/21 | |
Peter C. Hodge
IRC | Investor Relations Contact | - | - |
Karen Brunke
PRN | Corporate Officer/Principal | 72 | 09/09/21 |
Ian Wendt
PRN | Corporate Officer/Principal | - | - |
David Sesin
PRN | Corporate Officer/Principal | - | - |
Steven King
PRN | Corporate Officer/Principal | 66 | 01/01/04 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Lisa Conte
FOU | Founder | 65 | 06/06/13 |
James Bochnowski
CHM | Chairman | 80 | 01/02/14 |
John Micek
BRD | Director/Board Member | 71 | 01/04/16 |
Jonathan Siegel
BRD | Director/Board Member | 50 | 29/03/18 |
Director/Board Member | 67 | 01/07/22 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 0 | 9 | 0 | 0 | 92,16 % |
Acción B | 1 | 276 216 260 | 254 562 311 ( 92,16 %) | 0 |
Información de la empresa
Sector
Ventas por actividad
Varia. 1 de ene. | Capi. | |
---|---|---|
+2,95 % | 108 mil M | |
+10,33 % | 105 mil M | |
+1,57 % | 23,46 mil M | |
-12,41 % | 21,72 mil M | |
-7,05 % | 18,64 mil M | |
-37,64 % | 17,45 mil M | |
-6,58 % | 17,19 mil M | |
+6,00 % | 13,99 mil M | |
+36,98 % | 12,53 mil M |